40 years after the discovery of Helicobacter pylori: towards elimination of H pylori for gastric cancer prevention

doi:10.1016/S0140-6736(24)01171-1

Comment

. 2024 Jun 15;403(10444):2570-2572.

doi: 10.1016/S0140-6736(24)01171-1.

40 years after the discovery of Helicobacter pylori: towards elimination of H pylori for gastric cancer prevention

Jyh-Ming Liou¹, Peter Malfertheiner², Stella Ifeanyi Smith³, Emad M El-Omar⁴, Ming-Shiang Wu⁵

Affiliations

¹ Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 10051, Taiwan.
² University Hospital, Ludwig-Maximilians-Universität, Munich, Germany.
³ Nigerian Institute of Medical Research, Lagos, Nigeria.
⁴ UNSW Sydney, Sydney, NSW, Australia.
⁵ Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 10051, Taiwan. Electronic address: mingshiang@ntu.edu.tw.

PMID: 38879242
DOI: 10.1016/S0140-6736(24)01171-1

Comment

40 years after the discovery of Helicobacter pylori: towards elimination of H pylori for gastric cancer prevention

Jyh-Ming Liou et al. Lancet. 2024.

. 2024 Jun 15;403(10444):2570-2572.

doi: 10.1016/S0140-6736(24)01171-1.

Authors

Jyh-Ming Liou¹, Peter Malfertheiner², Stella Ifeanyi Smith³, Emad M El-Omar⁴, Ming-Shiang Wu⁵

Affiliations

¹ Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 10051, Taiwan.
² University Hospital, Ludwig-Maximilians-Universität, Munich, Germany.
³ Nigerian Institute of Medical Research, Lagos, Nigeria.
⁴ UNSW Sydney, Sydney, NSW, Australia.
⁵ Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 10051, Taiwan. Electronic address: mingshiang@ntu.edu.tw.

PMID: 38879242
DOI: 10.1016/S0140-6736(24)01171-1

No abstract available

PubMed Disclaimer

Conflict of interest statement

PM declares honoraria for lectures sponsored by Alfasigma, Allergosan, Bayer, Biocodex, and Menarini. J-ML declares honoraria for lectures sponsored by Biocodex and a research grant for an investigator-initiated trial from Takeda. All other authors declare no competing interests. During the preparation of this Comment, the authors used ChatGPT version 3.5 in order to improve language and readability; after using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.

Comment on

Ulcers, stress, and the discovery of Helicobacter pylori.
Crenner C. Crenner C. Lancet. 2024 Jun 15;403(10444):2586-2587. doi: 10.1016/S0140-6736(24)01206-6. Lancet. 2024. PMID: 38880103 No abstract available.

Cited by

Association of the atherogenic index of plasma and modified triglyceride-glucose indices with digestive diseases among middle-aged and older population in China.
Gao T, Ren M, Feng Y, Li Y, Zhang X, He S. Gao T, et al. Lipids Health Dis. 2024 Nov 30;23(1):398. doi: 10.1186/s12944-024-02321-8. Lipids Health Dis. 2024. PMID: 39616367 Free PMC article.
Application of Fourier transform infrared spectroscopy to exhaled breath analysis for detecting helicobacter pylori infection.
Qiu M, Liao F, Tan Y, Zhang J, Zheng C, Wang H, Zhuang H, Xiong W, Xie Q, Dong W. Qiu M, et al. Sci Rep. 2024 Dec 28;14(1):31542. doi: 10.1038/s41598-024-83360-0. Sci Rep. 2024. PMID: 39732993 Free PMC article.
Managing Helicobacter pylori: elimination challenges.
Rahimi F, Talebi Bezmin Abadi A. Rahimi F, et al. Therap Adv Gastroenterol. 2025 Apr 29;18:17562848251336293. doi: 10.1177/17562848251336293. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 40308455 Free PMC article. No abstract available.
Increasing our knowledge about the epidemiology of Helicobacter pylori in Nunavik's Inuit population (Québec, Canada) using Qanuilirpitaa? 2017 cross-sectional survey.
Ducrocq J, Lévesque B, De Serres G, Boiteau V, Yansouni CP, Proulx JF, Talbot D. Ducrocq J, et al. Int J Circumpolar Health. 2024 Dec;83(1):2398864. doi: 10.1080/22423982.2024.2398864. Epub 2024 Sep 16. Int J Circumpolar Health. 2024. PMID: 39283038 Free PMC article.
Ten-day vonoprazan-amoxicillin dual therapy versus 14-day esomeprazole-amoxicillin dual therapy for first-line Helicobacter pylori eradication: a prospective multicenter randomized controlled trial.
Zhou BG, Guo MW, Zhang LJ, Liu ZD, Liu CH, Li XF, Li SS, Xiao P, Bao B, Ai YW, Ding YB. Zhou BG, et al. Therap Adv Gastroenterol. 2024 Dec 27;17:17562848241309870. doi: 10.1177/17562848241309870. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39741655 Free PMC article.

See all "Cited by" articles

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

40 years after the discovery of Helicobacter pylori: towards elimination of H pylori for gastric cancer prevention

Affiliations

40 years after the discovery of Helicobacter pylori: towards elimination of H pylori for gastric cancer prevention

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical